A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) as Maintenance Treatment in Patients With Metastatic Colorectal Cancer
Clinical trial NCT00623805 · COMPLETED
Trial details
- NCT number
- NCT00623805
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2012-05-01
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.